ATA901478A - Verfahren zur herstellung neuer heterocyclischer anticholinergischer substanzen - Google Patents
Verfahren zur herstellung neuer heterocyclischer anticholinergischer substanzenInfo
- Publication number
- ATA901478A ATA901478A AT0901478A AT901478A ATA901478A AT A901478 A ATA901478 A AT A901478A AT 0901478 A AT0901478 A AT 0901478A AT 901478 A AT901478 A AT 901478A AT A901478 A ATA901478 A AT A901478A
- Authority
- AT
- Austria
- Prior art keywords
- producing new
- new heterocyclic
- anticholinergic substances
- anticholinergic
- substances
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/90—Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86121077A | 1977-12-16 | 1977-12-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA901478A true ATA901478A (de) | 1981-08-15 |
AT366380B AT366380B (de) | 1982-04-13 |
Family
ID=25335183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0901478A AT366380B (de) | 1977-12-16 | 1978-12-18 | Verfahren zur herstellung neuer heterocyclischer anticholinergischer substanzen |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5498711A (de) |
AR (1) | AR222478A1 (de) |
AT (1) | AT366380B (de) |
AU (1) | AU531835B2 (de) |
CA (1) | CA1102345A (de) |
DE (1) | DE2854308A1 (de) |
DK (1) | DK534178A (de) |
ES (1) | ES476048A1 (de) |
FR (1) | FR2422624A1 (de) |
GB (1) | GB2010270B (de) |
IE (1) | IE48012B1 (de) |
IT (1) | IT1101735B (de) |
NL (1) | NL7812257A (de) |
NO (1) | NO148776C (de) |
SE (1) | SE436027B (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3045055A1 (de) * | 1980-11-29 | 1982-07-01 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Heterocyclische verbindungen |
JPS5993075A (ja) * | 1982-11-18 | 1984-05-29 | Shionogi & Co Ltd | 1−フタリジル−5−フルオロウラシル誘導体の製造法 |
US4824676A (en) * | 1984-10-11 | 1989-04-25 | Schering Corporation | Physiological means of enhancing transdermal delivery of drugs |
US5008111A (en) * | 1984-10-11 | 1991-04-16 | Schering Corporation | Physiological means of enhancing transdermal delivery of drugs |
FR2703046B1 (fr) * | 1993-03-26 | 1995-05-05 | Poudres & Explosifs Ste Nale | Procédé de préparation d'oxalates et d'halogénoglyoxalates alpha- monohalogénés et nouveaux oxalates et halogénoglyoxalates alpha-monohalogénés . |
AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US5962505A (en) * | 1998-08-31 | 1999-10-05 | Bobrove; Arthur M. | Method for treating hot flashes in humans |
US6433003B1 (en) | 1999-04-23 | 2002-08-13 | Arthur M. Bobrove | Method for treating hyperhidrosis in mammals |
AR044134A1 (es) | 2003-05-02 | 2005-08-24 | Novartis Ag | Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas. |
EP1896038B1 (de) | 2005-06-03 | 2016-11-09 | Acrux DDS Pty Ltd | Verfahren und zusammensetzung für die transdermale abgabe von testosteron |
JP2009522246A (ja) * | 2005-12-30 | 2009-06-11 | ランバクシー ラボラトリーズ リミテッド | ムスカリン性レセプターアンタゴニスト |
DK2214643T3 (da) | 2007-11-02 | 2014-05-26 | Acrux Dds Pty Ltd | Transdermalt frigivelsessystem til hormoner og steroider |
JP6621329B2 (ja) * | 2012-10-05 | 2019-12-18 | スファエラ ファーマ ピーティーイー リミテッド | 新規化合物、それらの合成及びそれらの使用 |
DE102013013397A1 (de) | 2013-08-13 | 2015-03-12 | Epinamics Gmbh | Aerosolspender für transdermal wirkende pharmazeutische Zusammensetzungen |
CN110041264A (zh) * | 2019-04-11 | 2019-07-23 | 贺州学院 | 一种金刚烷基咪唑类离子液体及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL101555C (de) * | 1955-03-19 | |||
BE798253A (nl) * | 1973-04-16 | 1973-10-16 | Bekaert Sa Nv | Zitmeubel |
US3998815A (en) * | 1974-06-24 | 1976-12-21 | Interx Research Corporation | 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts |
-
1978
- 1978-11-29 DK DK534178A patent/DK534178A/da not_active Application Discontinuation
- 1978-12-12 IT IT30735/78A patent/IT1101735B/it active
- 1978-12-15 DE DE19782854308 patent/DE2854308A1/de not_active Withdrawn
- 1978-12-15 JP JP15601378A patent/JPS5498711A/ja active Pending
- 1978-12-15 SE SE7812911A patent/SE436027B/sv unknown
- 1978-12-15 NO NO784229A patent/NO148776C/no unknown
- 1978-12-15 ES ES476048A patent/ES476048A1/es not_active Expired
- 1978-12-15 AR AR274836A patent/AR222478A1/es active
- 1978-12-18 IE IE2499/78A patent/IE48012B1/en unknown
- 1978-12-18 AU AU42646/78A patent/AU531835B2/en not_active Expired
- 1978-12-18 AT AT0901478A patent/AT366380B/de active
- 1978-12-18 FR FR7835596A patent/FR2422624A1/fr active Granted
- 1978-12-18 GB GB7848850A patent/GB2010270B/en not_active Expired
- 1978-12-18 NL NL7812257A patent/NL7812257A/xx not_active Application Discontinuation
- 1978-12-18 CA CA318,112A patent/CA1102345A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NO148776B (no) | 1983-09-05 |
IE48012B1 (en) | 1984-09-05 |
NO784229L (no) | 1979-06-19 |
DE2854308A1 (de) | 1979-06-21 |
AU4264678A (en) | 1979-06-21 |
NL7812257A (nl) | 1979-06-19 |
FR2422624B1 (de) | 1983-10-14 |
ES476048A1 (es) | 1979-11-01 |
SE7812911L (sv) | 1979-06-17 |
FR2422624A1 (fr) | 1979-11-09 |
JPS5498711A (en) | 1979-08-03 |
IT7830735A0 (it) | 1978-12-12 |
IT1101735B (it) | 1985-10-07 |
IE782499L (en) | 1979-06-16 |
SE436027B (sv) | 1984-11-05 |
GB2010270A (en) | 1979-06-27 |
GB2010270B (en) | 1982-10-20 |
DK534178A (da) | 1979-06-17 |
CA1102345A (en) | 1981-06-02 |
AR222478A1 (es) | 1981-05-29 |
AU531835B2 (en) | 1983-09-08 |
AT366380B (de) | 1982-04-13 |
NO148776C (no) | 1983-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT363078B (de) | Verfahren zur herstellung neuer benzimidazol-derivate | |
AT364095B (de) | Verfahren zur herstellung neuer peptidderivate | |
AT368755B (de) | Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate | |
AT373251B (de) | Verfahren zur herstellung neuer d-6-n-propylergoline | |
AT366380B (de) | Verfahren zur herstellung neuer heterocyclischer anticholinergischer substanzen | |
LU79235A1 (de) | Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern | |
ATA246780A (de) | Verfahren zur herstellung neuer pyrazinobenzodiazepine | |
AT360553B (de) | Verfahren zur herstellung neuer nitroso- harnstoffverbindungen | |
AT367403B (de) | Verfahren zur herstellung neuer chinolin-2onderivate | |
AT363077B (de) | Verfahren zur herstellung neuer benzimidazol-derivate | |
DD136135A5 (de) | Verfahren zur herstellung neuer pyrrolidinverbindungen | |
AT358601B (de) | Verfahren zur herstellung neuer nitrosoharn- stoff-derivate | |
PT71116A (de) | Verfahren zur herstellung neuer cyclobutandicarbonsaureimide | |
DD138211A5 (de) | Verfahren zur herstellung neuer aminopyrimidin-verbindungen | |
AT357551B (de) | Verfahren zur herstellung neuer azetidinon- derivate | |
ATA90478A (de) | Verfahren zur herstellung neuer everninomicin- derivate | |
AT361640B (de) | Verfahren zur herstellung neuer 3beta-substi- tuierter 18-beta-olean-9-en-30-oylsaeure- derivate | |
AT356294B (de) | Verfahren zur herstellung neuer ergolinderivate | |
AT360998B (de) | Verfahren zur herstellung neuer n-pyrimidinyl- -imidsaeureester | |
DD138318A5 (de) | Verfahren zur herstellung neuer substituierter heterocyclylverbindungen | |
AT380014B (de) | Verfahren zur herstellung neuer oxazolidin-2-on- derivate | |
PT67639A (de) | Verfahren zur herstellung neuer indolylglyoxylsaeurederivate | |
ATA590179A (de) | Verfahren zur herstellung neuer 2-aminotetraline | |
DD133799A1 (de) | Verfahren zur herstellung neuer n-heterocyclisch substituierter adamantancarbonsaeureamide | |
AT373240B (de) | Verfahren zur herstellung neuer pyridyloxyphenoxyalkancarbonsaeurederivate |